ENvue Medical, Inc., was incorporated in Delaware on October 20, 2003. ENvue Medical operates through two wholly owned subsidiaries: NanoVibronix Ltd., located in Israel, and ENvue Medical Holdings LLC, located in Delaware. Nano OpCo focuses on the development of non-invasive biological reaction activation devices that can be used to prevent biofilm formation, relieve pain and promote wound healing, and can be used at home without the assistance of medical professionals. ENvue is a medical device company engaged in the research and development, production, marketing and sales of medical devices in the field of enteral nutrition.
